Podcast
October 5, 2023
Showing 21 - 30 of 113 results
JAMDA
September 25, 2023
Antipsychotic Drug Reduction through the Implementation of a Neurologically Oriented, Interdisciplinary Psycho-Diagnostic and Antipsychotic Stewardship Program
Antipsychotic utilization in skilled nursing facilities (SNFs) is a major focus of regulatory compliance and a key theme in resident care. This created opportunities for innovations in clinical care of behavioral and psychological symptoms of dementia (BPSD). In a shared initiative with one of our SNF oper...
JAMDA
August 12, 2023
Deprescribing Interventions for Older Patients: A Systematic Review and Meta-Analysis
Deprescribing reduces polypharmacy in older adults. A thorough study of the effect of deprescribing interventions on clinical outcomes in older adults is presently lacking. As a result, we evaluated the impact of deprescribing on clinical outcomes in older patients.
JAMDA
August 4, 2023
Long-Term Opioid Use and Dementia Risk in Patients With Chronic Pain
This study aimed to investigate the association between long-term opioid use and the risk of dementia in patients with chronic pain.
Spotlight
July 27, 2023
The Past, Present, and Future of Deprescribing
AMDA’s Drive to Deprescribe (D2D) initiative put practitioners behind the wheel on medication optimization. During a recent AMDA On-The-Go podcast, guest host Jennifer Pruskowski, PharmD, MS, BCPS, BCGP, CPE, sat down with Michael Steinman, MD, co-director of the U.S. Deprescribing Research Network, to tal...
JAMDA
July 18, 2023
Acute Antipsychotic Use and Presence of Dysphagia Among Older Veterans with Heart Failure
Examine whether new antipsychotic (AP) exposure is associated with dysphagia in hospitalized patients with heart failure (HF).
Podcast
June 29, 2023
AMDA On-The-Go | The Past, Present & Future of Deprescribing Research (D2D Special Edition)
JAMDA
June 17, 2023
Post Hoc Analyses of a Randomized Controlled Trial for the Effect of Pharmacist Deprescribing Intervention on the Anticholinergic Burden in Frail Community-Dwelling Older Adults
Anticholinergic burden is detrimental to cognitive health. Multiple studies found that a high anticholinergic burden is associated with an increased risk for dementia, changes to the brain structure, function, and cognitive decline. We performed a post hoc analysis of a randomized controlled deprescribing ...
Podcast
June 5, 2023
Caring On-The-Go | June & July 2023
JAMDA
May 22, 2023
Factors Associated With Benzodiazepine and Antipsychotic Prescribing in Hospice: A Qualitative Study of Hospice Prescribers
Benzodiazepine and antipsychotic medications are common components of the hospice toolkit and are routinely prescribed for behavioral symptom management at end of life. These medications have significant associated risks but, despite their frequent use, little is known about how clinicians weigh prescribin...
